Population
Ambulatory patients with nonvalvular atrial fibrillation receiving care within a health maintenance…
Design
Cohort
Authors
Loading...
Persistent anticoagulation gaps in eligible AF patients; leaves open questions on implementation barriers in real-world cohorts.
Despite higher overall use than previously reported, a significant proportion of eligible patients with atrial fibrillation and stroke risk factors still do not receive indicated warfarin therapy.
Go et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: